brownecfm
'Collectively, the observed neuropathology and unique molecular markers of neurodegenerative disease progression provide a novel mechanism by which COVID-19 may promote dementia/AD by contributing to pericyte loss and BBB dysfunction during infection'. This is why I mask.
Vipin M. Vashishtha
Could COVID-19 accelerate the path toward Alzheimer’s disease? ➡️ A striking new study shows that SARS-CoV-2 damages brain pericytes—the specialized vascular cells that maintain the blood–brain barrier (BBB) and help clear amyloid-β. ➡️ Remarkably, pericyte loss, persistent neuroinflammation, elevated amyloid-β, neuronal loss, and activation of Alzheimer’s-related genes all persisted long after the virus had been cleared from the brain. 1/
